These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1316357)

  • 1. The insulin-binding domain of insulin receptor is encoded by exon 2 and exon 3.
    Yip CC
    J Cell Biochem; 1992 Jan; 48(1):19-25. PubMed ID: 1316357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin/IGF-1 hybrid receptors: implications for the dominant-negative phenotype in syndromes of insulin resistance.
    Frattali AL; Treadway JL; Pessin JE
    J Cell Biochem; 1992 Jan; 48(1):43-50. PubMed ID: 1316361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM
    EXS; 1993; 65():131-65. PubMed ID: 8380735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a second ligand binding site of the insulin receptor.
    Hao C; Whittaker L; Whittaker J
    Biochem Biophys Res Commun; 2006 Aug; 347(1):334-9. PubMed ID: 16814253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The structure function relationship in the human insulin receptor].
    Kishimoto M; Hashiramoto M; Kasuga M
    Nihon Rinsho; 1994 Oct; 52(10):2616-22. PubMed ID: 7983787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin and IGF-1 receptors contain covalently bound palmitic acid.
    Magee AI; Siddle K
    J Cell Biochem; 1988 Aug; 37(4):347-57. PubMed ID: 2843552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics of insulin/IGF-I receptor transmembrane signaling.
    Pessin JE; Frattali AL
    Mol Reprod Dev; 1993 Aug; 35(4):339-44; discussion 344-5. PubMed ID: 8398111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin internalization in the absence of the insulin receptor tyrosine kinase domain is insufficient for mediating intracellular biological effects.
    Schranz DB; Rohilla AM; Anderson C; Wood WM; Berhanu P
    Biochem Biophys Res Commun; 1996 Oct; 227(2):600-7. PubMed ID: 8878559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic evidence for the sequential association of insulin binding sites 1 and 2 to the insulin receptor and the influence of receptor isoform.
    Thorsøe KS; Schlein M; Steensgaard DB; Brandt J; Schluckebier G; Naver H
    Biochemistry; 2010 Jul; 49(29):6234-46. PubMed ID: 20568733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemical structure, active sites and receptor binding of insulin molecule and its signal transduction].
    Ishida H; Nagamatsu S
    Nihon Rinsho; 2001 Nov; 59(11):2109-16. PubMed ID: 11712394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding properties of chimeric insulin receptors containing the cysteine-rich domain of either the insulin-like growth factor I receptor or the insulin receptor related receptor.
    Zhang B; Roth RA
    Biochemistry; 1991 May; 30(21):5113-7. PubMed ID: 1645190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site.
    Kjeldsen T; Andersen AS; Wiberg FC; Rasmussen JS; Schäffer L; Balschmidt P; Møller KB; Møller NP
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4404-8. PubMed ID: 1852007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors.
    Schumacher R; Mosthaf L; Schlessinger J; Brandenburg D; Ullrich A
    J Biol Chem; 1991 Oct; 266(29):19288-95. PubMed ID: 1655782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between alpha subunit ligand occupancy and beta subunit autophosphorylation in insulin/insulin-like growth factor-1 hybrid receptors.
    Frattali AL; Pessin JE
    J Biol Chem; 1993 Apr; 268(10):7393-400. PubMed ID: 8463272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras.
    Gustafson TA; Rutter WJ
    J Biol Chem; 1990 Oct; 265(30):18663-7. PubMed ID: 2170418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin and insulinlike growth factor 1 (IGF-1) receptors during central nervous system development: expression of two immunologically distinct IGF-1 receptor beta subunits.
    Garofalo RS; Rosen OM
    Mol Cell Biol; 1989 Jul; 9(7):2806-17. PubMed ID: 2476658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An extracellular domain of the beta subunit is essential for processing, transport and kinase activity of insulin receptor.
    Haruta T; Sawa T; Takata Y; Imamura T; Takada Y; Morioka H; Yang GH; Kobayashi M
    Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):599-604. PubMed ID: 7832779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a ligand-binding region of the human insulin receptor encoded by the second exon of the gene.
    De Meyts P; Gu JL; Shymko RM; Kaplan BE; Bell GI; Whittaker J
    Mol Endocrinol; 1990 Mar; 4(3):409-16. PubMed ID: 2188117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing the insulin receptor to possess insulin-like growth factor I ligand specificity.
    Andersen AS; Kjeldsen T; Wiberg FC; Christensen PM; Rasmussen JS; Norris K; Møller KB; Møller NP
    Biochemistry; 1990 Aug; 29(32):7363-6. PubMed ID: 2223767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the exon 11 of the insulin receptor gene on insulin binding identified by anti-peptide antibodies.
    Sesti G; Tullio AN; Marini MA; Manera E; Borboni P; Accili D; Longhi R; Fusco A; Lauro R; Montemurro A
    Mol Cell Endocrinol; 1994 May; 101(1-2):121-7. PubMed ID: 9397944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.